A Double-blind Placebo Controlled Study of Desipramine in the Treatment of ADD: II. Serum Drug Levels and Cardiovascular Findings

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 28, Issue 6, 1989, Pages 903-911

  BIEDERMAN, JOSEPH ^a   BALDESSARINI, ROSS J ^b   WRIGHT, VIRGINIA ^a   KNEE, DEBRA ^a   HARMATZ, JEROLD S ^c   GOLDBLATT, ALLAN ^a,d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b MCLEAN HOSPITAL   (United States)

^c TUFTS MEDICAL CENTER   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

attention deficit disorder; cardiovascular effects; desipramine; serum levels

Indexed keywords

DESIPRAMINE;

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; BLOOD PRESSURE; CHILD; CLINICAL ARTICLE; DRUG BLOOD LEVEL; HEART RATE; HUMAN; HYPERACTIVITY; ORAL DRUG ADMINISTRATION; TACHYCARDIA;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CARDIOVASCULAR SYSTEM; CHILD; DESIPRAMINE; DOUBLE-BLIND METHOD; HEART BLOCK; HUMAN; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0024804130     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004583-198911000-00015     Document Type: Article

References (43)

1. A double-blind placebo controlled study of desipramine in the treatment of ADD: I. Efficacy
2. Cardiovascular effects of desipramine in children and adolescents with attention deficit disorder
3. Desipramine in the treatment of children with attention deficit disorder
4. Treatment of childhood hyperactivity with desipramine: plasma drug concentration, cardiovascular effects, plasma and urinary catecholamine levels, and clinical response
5. Tricyclic antidepressants and methylphenidate treatment of attention deficit disorder in children
6. Desipramine in the treatment of adolescents with attention deficit disorder
7. Desipramine in the treatment of attention deficit disorder in adolescents
8. Child and adolescent nortriptyline single dose pharmacokinetic parameters: final report
9. Diagnosis and drug treatment of childhood disorders
10. Controlled imipramine treatment of school phobia
11. Cardiovascular effects of therapeutic doses of tricyclic antidepressants: a review
12. Clinical characteristics of imipramine-induced orthostatic hypotension
13. The use of imipramine in depressed patients with congestive heart failure
14. Blood pressure and pulse changes in hyperactive children with imipramine and methylphenidate
15. Incidence of orthostatic hypotension in patients with primary affective disorders treated with tricyclic antidepressants
16. Imipramine dosage in children: a comment on imipramine and electrocardiographic abnormalities in hyperactive children
17. Pharmacokinetics of psychotropic drugs: what can it tell us?
18. Effects of several tricyclic antidepressants on the hemodynamics and myocardial contractility of anesthetized dogs
19. Psychotropic drug disposition during development
20. Effects of imipramine on norepinephrine and blood pressure in enuretic boys
21. Noninvasive Investigations
22. The hypotensive effect of imipramine hydrochloride in patients with cardiovascular disease
23. Depression in children: relationship between plasma imipramine levels and response
24. Plasma levels of imipramine and adverse effects in children
25. Plasma levels of imipramine (IMI) and desmethylimipramine (DMI) and clinical response in prepubertal major depressive disorder
26. Imipramine in prepubertal major depressive disorders
27. Antidepressants
28. Tricyclic antidepressants in depressed patients with cardiac conduction disease
29. Pharmacokinetics of Antidepressants
30. Imipramine in adolescent major depression: plasma level and clinical response
31. Relative safety of single versus divided dose of imipramine in adolescent major depression
32. Imipramine side effects in children
33. EKG effects of imipramine treatment in children
34. Disorders of conduction
35. Cardiovascular effects of therapeutic doses of tricyclic antidepressants in depressed patients with chronic heart disease
36. Steady-state plasma imipramine levels in prepubertal children
37. Imipramine and electrocardiographic abnormalities in hyperactive children
38. Tricyclic antidepressants and children